Proficiency Results From Your Peers at EULAR 2018 and Beyond

4 Years, 16 Live & Online Activities, 6000+ Clinicians: What we’ve learned so far

RMEI has released pairings of live and online programs approximately twice per year since 2016 grouped into “phases” which share clinical areas of focus and are based on findings from the previous phase of education. In total, 16 activities have launched to date with 4 activities currently live. The purpose of this analysis is to better understand the impact of multi-year iterative education on a clinical audience. Research with Preliminary Data – research projects that have collected data and are in the process of analyzing that data against the project’s hypothesis or objectives.

Presentation Year: 2021

Presented at: Accreditation Countil for Continuing Medical Education (ACCME), Society for Academic CME (SACME)

Allergy & Immunology
Presented 2021

Effectiveness of 5-year IBD Provider Online Educational Intervention Program

There is considerable practice variability among providers caring for inflammatory bowel disease (IBD) patients. Limited data exists on the effectiveness of educational interventions targeting IBD providers to address these gaps. We report outcomes for a 5-year provider education training program which culminated in an enduring online education resource and clinical decision support tool.

Presentation Year: 2021

Presented at: Accreditation Countil for Continuing Medical Education (ACCME), Digestive Disease Week (DDW)

Gastroenterology
Presented 2021

Iterative Data-Driven Education for Evolving Strategies of Care in cSCC

The incidence of cutaneous squamous cell carcinoma (cSCC) is growing in the United States and epidemiologic data are likely to have underestimated the burden of the disease. New therapies are emerging for the management of advanced/unresectable cSCC that have the potential to alter outcomes. Clinicians need to be made aware of these new options and how they can be integrated into clinical practice. Dermatologists and Mohs surgeons will need to identify patients who are not surgical candidates and engage a multidisciplinary team to discuss systemic options, such as immunotherapy and optimal management approaches. To address the challenges facing clinicians in the appropriate alignment of treatment to patient, a 3-activity curriculum was developed. This curriculum was hosted online for one year, and findings from this education will be used to develop future content.

Presentation Year: 2020

Presented at: European Association of Dermato Oncology (EADO)

Hematology / Oncology
Presented 2020

Multi-Year Analysis of Transplant Education 2016-2018

Over a 3-year period from 2016 to 2018, RMEI produced 10 live and 5 enduring online medical education courses that addressed optimal strategies for managing AMR and CMV in SOT patients, and CMV in HSCT patients. The education targeted both domestic and international audiences. Key: antibody-mediated rejection (AMR); cytomegalovirus (CMV); hematopoietic stem cell transplantation (HSCT); solid organ transplantation (SOT).

Presentation Year: 2019

Presented at: American Board of Medical Specialties (ABMS)

Transplant
Presented 2019

Optimizing treatment in BCC and CSCC: 3 years of oncology CME

Poster presented at 19th EADO Congress, April 20-22nd, 2023.

Presentation Year: 2023

Presented at: European Association of Dermato Oncology (EADO)

Hematology / Oncology
Presented 2023